Logo image
Clinical and Histopathologic Characteristics of Pediatric Patients with Primary Membranous Nephropathy
Journal article   Open access   Peer reviewed

Clinical and Histopathologic Characteristics of Pediatric Patients with Primary Membranous Nephropathy

Anne M. Kouri, Tiffany N. Caza, Laurence H. Beck, Jason M. Misurac, Michael D. Evans, Carrie L. Phillips, Michael T. Eadon, Christopher P. Larsen, Sharon P. Andreoli, Lihong Bu, …
Kidney international reports, Vol.8(11), pp.2368-2375
11/2023
DOI: 10.1016/j.ekir.2023.08.018
PMCID: PMC10658230
PMID: 38025223
url
https://doi.org/10.1016/j.ekir.2023.08.018View
Published (Version of record) Open Access

Abstract

Introduction Primary membranous nephropathy (PMN) is uncommon in children. As such, data on the clinical course of affected children are scarce. In recent years, several novel antigens have been implicated in the pathogenesis of PMN. However, the histopathologic characteristics of pediatric patients with PMN remain poorly represented in the literature. Methods We have retrospectively analyzed the clinical presentation and outcomes data of 21 children with PMN from 3 centers in the United States. In addition, we have identified novel antigens in biopsy specimens from these patients and correlated their presence or absence to clinical outcomes. Finally, we compared the results of the novel antigen staining from our clinical cohort to a validation cohort of 127 biopsy specimens from children with PMN at Arkana Laboratories. Results The data from the two cohorts demonstrated similar overall antigen positivity rates of 62— 63%, with PLA2R and EXT1 being the most commonly found antigens. Results from the clinical cohort showed that overall, the kidney prognosis for children with PMN was good, with 17/21 patients entering a complete or partial remission. Children who were positive for PLA2R or EXT1 were significantly more likely to enter remission than those in the antigen negative group. Conclusion Approximately 60% of pediatric membranous cases are positive for a novel antigen on kidney biopsy and the clinical prognosis is generally favorable. More studies are needed to understand the clinical implications of each specific novel antigen.

Details

Logo image